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Abstract 
Pain assessment and management is a fundamental part of nursing care. Opioids are 1 of 
the interventions utilized to manage pain within the hospital setting and have a known 
adverse effect called opioid-induced sedation and respiratory depression (OSRD). The 
purpose of this quantitative study was to create a prediction model with the known risk 
factors present on admission, to determine how well they predict OSRD. This served as a 
first step in the creation of a risk screen tool, supported by the cognitive continuum 
theory, in understanding the judgment and decision-making process to provide safe care. 
The combination of factors that most accurately predicted the risk of OSRD in patients on 
admission to an acute care healthcare institution was determined through a retrospective 
case control analysis. Risk factors present on admission of a case group of 100 patients 
who had succumbed to OSRD after an opioid administration were matched and compared 
to a control group of 100 who did not. A binary logistic regression analysis was used to 
determine how well age, body mass index, obstructive sleep apnea, pulmonary disease, 
respiratory disease, renal failure, and no opioid use (i.e., being opioid naïve) predicted 
OSRD. The presence of pulmonary disease, renal disease, cardiac disease, diabetes, and 
being opioid naïve most accurately predicted OSRD. Although only pulmonary disease 
and renal disease were statistically significant, the final model included other factors that 
increase the odds of OSRD, which are encompassed in the proposed tool for future 
research. Through understanding the factors that predict OSRD, a screening tool was 
created that could save lives in hospital institutions and lead to positive social change by 
supporting clinical decision making and care.   
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Chapter 1: Introduction to the Study 
Introduction  
Pain assessment and management is an integral part of nursing care. Opioids are 
one of the interventions utilized to manage pain within the hospital setting. A full 
understanding of the risks of oversedation from opioids is essential when a patient 
presents to the hospital setting. Publicized as the opioid epidemic, the public is becoming 
more aware of the dangers of opioids in relation to overdose and addiction (Frasier & 
Plescia, 2019). Opioid-induced sedation and respiratory depression (OSRD) is a known 
adverse effect associated with patients in the hospital setting (Jungquist, Smith, Wiltse 
Nicely, & Polomano, 2017). OSRD has other terms with similar meanings that are 
encompassed within OSRD or are closely related. These terms described in the literature 
include the following: opioid adverse drug events, opioid-induced respiratory depression 
(OIRD), opioid-induced oversedation, and opioid-induced ventilatory impairment (OIVI). 
The alternate terms are all similarly explained as difficulty arousing or decreased 
respiratory rate after administration of an opioid, often requiring reversal with an opioid 
antagonist, Naloxone (Rosenfeld et al., 2015). For this research, OSRD encompassed 
opioid adverse drug events, OIRD, opioid-induced sedation, and OIVI and was the 
primary descriptor, measured by the administration of Naloxone.  
In the hospital setting, OSRD events are reported by The Joint Commission (TJC; 
2012) as occurring in 0.5% of postsurgical patients, with this estimation thought to be 
low. TJC has suggested screening; however, there is no standardized method for 
predicting risk for OSRD. The risk factors for OSRD include: (a) age greater than 55 
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years, (b) obesity, (c) untreated obstructive sleep apnea, (d) preexisting 
pulmonary/cardiac disease or dysfunction, (e) major organ failure, (f) being a smoker, (g) 
American Society of Anesthesiologists (ASA) Patient Status Classification of  3 to 5, (h) 
being opioid naïve; (i) being opioid tolerant and given more than their usual amount, (j) 
high dose patient controlled analgesia; (k) in the first 24 hours of opioid therapy, (l) the 
presence of thoracic and other large incisions that may interfere with adequate 
ventilation, (m) concomitant administration of sedating agents, and (n) patients who have 
already received Naloxone for opioid reversal (Jungquist et al., 2017). While these 
factors can be used as a guide for assessment, not knowing how well each factor predicts 
ORSD limits the ability to accomplish this accurately. No scoring tool has been 
developed or tested that predicts the risk of OSRD on admission, which would allow 
nurses to accurately assess risk and provide appropriate interventions to manage risk and 
optimum pain management and monitoring. A screening tool based on the predictors of 
OSRD could assist clinicians in pain assessment and management. The first step in 
developing such a tool was to quantify the predictors for ORSD based on the factors in 
the literature. In this chapter, I provide a background of OSRD as well as explain the 
problem and purpose of the study. I also describe the research questions, theoretical 
underpinning, definitions, assumptions, scope, limitations, and significance of 
determining the factors that most predict OSRD.  
Background  
While healthcare providers are focused on adequate pain management, the 
challenge is providing pain management while preventing adverse events, such as 
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oversedation and respiratory depression. Opioid medications, commonly prescribed for 
pain, place the patient at risk for oversedation and respiratory depression (TJC, 2012). 
Assessing risk is essential in mitigating potential harm caused by any medication and 
needs to be included in the medication administration process (Centers for Medicare & 
Medicaid Services, 2014).  
Several studies have been conducted to assess predicting factors associated with 
OSRD, finding many overlapping risk factors, with some having more evidence 
supporting their contribution to risk over others. Most recently, Gupta et al. (2018) 
provided a review of 13 articles, stating the incidence of the adverse event of 
oversedation and respiratory depression in surgical patients ranged from 0.1% to 23.77%. 
They also listed several factors that increase a patient’s risk, such as age over 65, ASA of 
a 3 or 4, obstructive sleep apnea (OSA), chronic obstructive lung disease (COPD), 
cardiac disease, neurological disease, diabetes mellitus, female sex, hypertension, use of 
patient-controlled analgesia, using sedatives in addition to opioids, and giving opioids by 
varying routes and from varying prescribers. Minkowitz, Gruschkus, Shah, and Raju 
(2014) conducted a large retrospective cohort study and analyzed historical risk factors 
associated with an opioid-related adverse drug event of 6,285 surgical patients. They 
defined a broader range of opioid-related adverse events to include more than 
oversedation and respiratory depression, like ileus, pruritus, and constipation, which may 
explain why some of their risk factors were different than those in the literature linked to 
only oversedation. The differing risk factors included male gender, regional enteritis, 
diverticulitis, and ulcerative colitis, and the risk factors that are the same were age, prior 
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opioid use, COPD, and cardiac dysrhythmias (Minkowitz et al., 2014). Junquist et al. 
(2017) discussed the need for identifying patients at-risk for OSRD along with listing the 
factors recognized as increasing risk initially published by McCaffery and Pasero (2011). 
These factors have influenced many of the publications on risk factors for OSRD to date, 
including TJC’s (2012) recommendation that highlighted the first 24 hours postsurgery, 
OSA, increased body mass index, prior experience with opioids, and preexisting chronic 
pain as high-risk factors.  
No tool for screening to predict and stratify patients by their level of risk for 
OSRD has been published, and this represented the gap in the literature that I sought to 
fill with this study. The lack of effective means for screening and identifying patients at 
risk places a burden on patients, their families, and the health system. The financial costs 
of one serious ORSD event can be millions of dollars per claim and with incidences of 
OSRD up to 23% (Junquist et al., 2017). While financial consideration is necessary, 
patients’ lives are more important, and identifying potential at-risk individuals based on 
predictive factors can assist in instituting appropriate administration and monitoring 
practices to prevent harm (Junquist et al., 2017).  
Problem Statement 
Tools, developed as a method of predicting negative outcomes like OSRD, can 
inform nursing clinical decision-making, creating a streamlined process for the 
assessment of critical factors (Junquist el al, 2018). Risk factors associated with OSRD 
have been retrospectively analyzed, published, and recommended to assess by many 
nursing and accrediting bodies (TJC, 2012). To appropriately follow guidelines aimed at 
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improving patient safety, the risk factors available in the literature should be combined 
and validated as a tool that is easy to use. Many of the factors listed in the practice 
recommendation of the TJC (2012) continue to be supported by clinical evidence (e.g., 
Gupta et al (2018) analyzed multiple retrospective reviews, listing many of the same 
factors). Although the TJC recommended risk stratification for patients, clinicians do not 
have a standardized tool to complete the task based on the predictability of the variables 
that lead to ORSD. There is a gap in the literature because of the variability in evidence 
of the factors and the lack of an existing tool based on the predictors of OSRD. In this 
study, I sought to accomplish the first step in creating a tool by understanding which 
combination of published risk factors most predict OSRD to support clinical decision-
making in the care of patients receiving opioids for pain management. 
Purpose 
While the risk factors for OSRD are available in the literature (Jarzyna et al., 
2011; TJC, 2012; Jungquist et al., 2017), no scoring tool has been developed or tested to 
use for screening patients based on the risk factors that most predict OSRD. The purpose 
of this quantitative study was to create a prediction model based on published risk factors 
that are present on admission, which serve as the independent variables and are supported 
by the most current evidence. Independent variables for this study included OSA, obesity, 
age, pulmonary disease, cardiac disease, major organ failure, diabetes mellitus, and not 
currently taking opioids. The dependent variables were patients who had succumbed to 
OSRD and those who had not after receiving an opioid. After this initial study, I created a 
tool based on the predictive model to be further tested in subsequent studies. If an OSRD 
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screening tool were available, it could provide a means to recognize the need for 
appropriate interventions to manage risk and provide optimum pain management and 
monitoring. 
Research Questions 
Research Question: What combination of factors most accurately predict the risk 
of OSRD in patients on admission to an acute care healthcare institution? 
H0: The independent variables, which included the continuous variables of 
obesity, measured in BMI and age, and categorical variables as diagnosed 
yes or no, which included OSA, pulmonary disease, cardiac disease, major 
organ failure, diabetes mellitus, and no opioid exposure, do not predict the 
risk of OSRD.  
HA: The independent variables, which included the continuous variables of 
obesity, measured in BMI and age, and categorical variables as diagnosed 
yes or no, which included OSA, pulmonary disease, cardiac disease, major 
organ failure, diabetes mellitus, and no opioid exposure predict the risk of 
OSRD.  
Framework 
Completing a patient history assessment is essential to planning nursing 
interventions and decision-making. A simplified tool that evaluates risk factors to predict 
OSRD can assist in quick analysis and decision-making when managing pain with 
opioids. The cognitive continuum theory (CCT), introduced by Hammond (1981), is a 
theory that underpins the judgment and decision-making process. Hammond developed 
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the CCT by extending the work of another psychology theorist, Brunswikv (Dhami & 
Mumpower, 2018). Analysis and decision-making are crucial for every individual, but in 
the delivery of nursing care, judgment and decision-making are key to providing safe, 
effective, competent care.  
The CCT offers a theoretical framework for the processes involved in human 
thinking from a psychological perspective. Cader, Campbell, and Watson (2005) stated, 
“The more structured a task is, the more analytically induced will be the decision-making 
mode” (p. 399). Tools provide structure to support well-structured tasks. Per Hammond 
(1981), tasks are well-structured as opposed to ill-structured; however, both types of tasks 
are relevant in nursing and described in the CCT (Cader, et al., 2005). Intuition is also 
essential for clinical decision-making in practice and should be used in conjunction with 
the CCT (Cader, et al., 2005). Although a tool can assist and support decisions, nurses are 
still accountable and should use a complete patient assessment along with their clinical 
judgment to provide care to patients. In Chapter 2, I present more detail on the CCT.  
Nature of the Study  
In this study, I gathered quantitative data through a retrospective chart review 
with case-control analysis, based on the risk factors for OSRD the literature supports. 
Patient records were reviewed using a medical record-storing software. The evaluation of 
charts was conducted on patients who received Naloxone for opioid reversal for their 
pertinent medical history that related to the risk factors of OSRD for this study. The 
control group was retrieved through chart review and matched based on admitting 
diagnosis or surgical procedure and gender. I then developed the model and tested it with 
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logistic regressions (see Houser, 2015). Logistic regression helped me determine which 
risk factors, evidenced in the literature, were most predictive for OSRD.  
Definitions 
Historical factors: Demographic factors or diseases that a patient has before the 
surgical procedure or hospitalization, which often do not change throughout the stay 
unless there is a new diagnosis. In this study, I separated these factors from the practice 
factors that the TJC (2012) combined in their compilation. The demographic and 
comorbid factors considered as historical risk factors for OSRD are age, BMI, OSA or 
symptoms of OSA, pulmonary disease, cardiac disease, major organ failure, smoker, 
ASA patient classification, diabetes mellitus, COPD, opioid dependence, or no exposure 
to opioids (TJC, 2012). 
Opioid-induced respiratory depression (OIRD): When the respiratory rate and 
depth is reduced below the patient’s baseline after an opioid (Pasero & McCaffery, 
2011). While rates at less than eight breaths a minute are considered severe (Dahan, 
Aarts, & Smith, 2010), in their review, Gupta et.al. (2018) defined OIRD as “respiratory 
rate less than 10/min, and/or oxygen saturation less than 90%, Naloxone administration, 
other respiratory events like apnea, hypopnea, respiratory failure, and excessive sedation 
and upper airway obstruction” (p. 111).  
Opioid-induced sedation and respiratory depression (OSRD): The associated 
sedation or decreased level of consciousness that occurs with or without respiratory 
depression, which is considered a respiratory rate decreased from a patient’s typical rate, 
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after opioid administration (Pasero & McCaffery, 2011). Often these events require the 
reversal of the opioid using Naloxone, an opioid antagonist (Pasero & McCaffery, 2011).  
Opioid-induced sedation: OSRD includes opioid-induced sedation, but the 
literature recognizes it as a precursor of respiratory depression and is described separately 
(Pasero & McCaffery, 2011). Therefore, the early assessment of sedation is paramount in 
the detection of opioid adverse events.  
Opioid-induced ventilatory impairment (OIVI): Caused by the depression of the 
central nervous system after opioid administration, which causes a decrease in respiratory 
drive and cognitive function and impacts the strength of the muscles in the airway 
(Macintyre, Loadsman, & Scott, 2011).  
Naloxone administration: Naloxone is an opioid antagonist and reverses the 
effects of opioids in the body, including the adverse effects of sedation and respiratory 
depression, and is often used in organizations as a quality indicator (Rosenfeld et al., 
2016). It is a measurable outcome, although it may not encompass every instance of 
oversedation or respiratory depression because not every patient requires Naloxone for 
reversal as close monitoring and supplemental oxygen may suffice.  
Practice factors: The risk factors that are dependent on the patient’s surgery or 
circumstance and can change throughout their stay whether that be outpatient or 
inpatient, including the first 24 hours’ postanesthesia, prolonged surgery, surgical type, 
concomitant use of sedating agents, large boluses of opioids, and/or patient-controlled 
analgesia (TJC, 2012). 
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Pharmacogenetic factors:  The way that genes impact reactions to medications is 
called pharmacogenetics (Chianta & Guevara, 2014). There is a genetic variance in 
relation to opioids, and patients can be ultra-rapid metabolizers of opioids (Chianta & 
Guevara, 2014). This can place a patient at risk for oversedation and respiratory 
depression; however, it is not a typical item known to patients because it requires 
specialized genetic testing (Chianta & Guevara, 2014). When a patient does know they 
are an ultra-rapid metabolizer, it needs to be a part of the risk consideration for managing 
their pain, but because it is not a widespread test, it would not be a common comorbid 
condition to include in a simple screening tool. Gender is a demographic factor and is 
known to play a role in the pharmacogenetics because males and females experience pain 
and metabolize pain treatments differently (Packiasbapathy & Sadhasivam, 2018). Brant 
et al. (2018) listed female sex as a significant predictor of OSRD, while Minkowitz et al. 
(2014) listed male sex as a risk factor. Because there is a known difference 
pharmacodynamically with conflicting evidence supporting each gender as a factor, I 
used gender in sampling and matching case-controls for this study. 
Assumptions 
In this quantitative study, I assumed the sample data of patients who received 
Naloxone to be the same as what were in the literature. Likewise, I assumed Naloxone 
administration for untoward events caused by opioids was an appropriate outcome 
measure for OSRD. The control was purposefully sampled to ensure it was like the case 
group. Another assumption was that the care of the patients in each group was the 
standard of care for each surgical procedure and the competency and knowledge of the 
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nurses was also the same. This could not be controlled for, and therefore, an assumption 
was made about it. The items listed in the patient record were assumed to be an accurate 
representation of that patient and in the context of this study, trusting the accuracy of the 
patient record is imperative to complete the data extraction process. These assumptions 
were necessary to obtain access to a sample that likely represented the study population. 
Scope and Delimitations 
  With this study, I addressed the gap that existed concerning the lack of a 
formalized tool to assess risk factors based on their prediction of OSRD. This study 
included a retrospective examination of charts of hospitalized patients that were older 
than 18 years old and had risk factors for OSRD. The records of patients who had 
received Naloxone for reversal of opioids were examined and compared with a similar 
group of patients who did not require Naloxone for reversal after opioid administration. 
Because the number of patients who receive Naloxone after opioid management is small 
compared to all hospitalized patients requiring pain treatment, prospectively analyzing 
and reviewing patient histories, then comparing them, had to be a longitudinal study. At 
the time of the study, the current rate of Naloxone administration at the facility where the 
sample was studied was 0.2% per 1,000 patient days, which would have required 
extensive time if I had conducted a prospective study; therefore, I did not perform a 
prospective review. I conducted a retrospective analysis of records from 2016 to 2019 of 
patients who received Naloxone and an equal sample of patients who did not receive 
Naloxone, which was feasible and appropriate to answer the research question.  
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 I analyzed each chart for the factors in the literature that place a patient at risk for 
OSRD. Once all the factors were retrieved and reviewed, statistical analysis was 
conducted to determine the factors that are most predictive of OSRD on admission the 
hospital setting. Outpatients were not included in this analysis because they represent a 
different population with different factors. In the outpatient community, the focus is on 
predicting the risk of addiction and abuse or overdose (Zedler, Saunders, Joyce, Vick & 
Murrelle, 2018). Other theories and models related to nurse decision-making are 
available. The humanistic-intuitive model applies more to an emotional or personal 
context to decision-making (Muntean, 2012). While this approach is used to support 
decisions, in this research study, the easy-to-use tool that I designed with known factors 
did include emotional decision-making within its purpose. The information-processing 
model offers an analytical base to decision-making (Muntean, 2012). This model could 
inform a screening tool to support nursing decision-making but does not offer the 
application of intuition that is critical to nursing that the CCT supports. 
Limitations 
Due to the nature of a retrospective chart review, there were intrinsic limitations 
to the nonprospective, randomization of the cases. I matched the control sample for a 
surgical procedure or admitting diagnosis along with gender and randomization; 
however, this could have impacted the generalizability of the results. In this study, I used 
patient sample data from only one community-based hospital system, which was a 
limitation of the study. Another limitation was the potential that there may have been 
other patients who experienced OSRD that were not captured by the administration of 
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Naloxone and instead were caught early enough to provide close monitoring and 
stimulation to avoid Naloxone. Due to my experience of caring for patients receiving 
opioids, it is necessary to note that additional measures were taken to ensure that my 
previous experience did not bias the results because as the sole investigator gathering 
data from patient records, I used a systematic and documented protocol to retrieve 
accurate data points.  
Significance 
Preventing OSRD in hospitalized patients is of utmost importance. While it is the 
responsibility of a clinician to use their judgment in dosing opioids that are ordered 
(Jarzyna et al., 2011), a risk scoring prediction tool to alert the clinicians to potential 
adverse outcomes would provide another line of defense in preventing a sentinel event. 
Knowing how the factors predict OSRD is a meaningful step in the process to address the 
problem and stop it before it occurs rather than assessing for sedation and administering 
Naloxone after.  
Many tools have been previously developed to screen patients for other sentinel 
events like falls or pressure ulcers, and these serve to assist in clinical decision-making 
and warrant interventions to be taken to prevent such events (Kumar, Mahal, & Rajappa, 
2012). Alarmingly, the reporting of OSRD is thought to be less than the actual 
occurrence, with OSRD likely happening more often than the reported 0.5% of patients 
(TJC, 2012). This underreporting justifies the problem from a patient safety and quality 
standpoint. While organizations like TJC (2012) have suggested screening patients, there 
is no extant method of how to do this in a standardized way that improves patient 
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outcomes rather than following an arbitrary recommendation. A screening tool based on 
risk factors that predict OSRD will assist clinicians and promote positive social change 
by supporting clinical decision-making to prevent harm to individuals from opioid 
administration. Better pain assessment that includes screening for risk factors that predict 
OSRD will also lead to a positive social change by preventing injury as severe as death 
for individuals seeking care and pain management within a hospital setting.  
Summary  
Providing safe, effective pain management is a primary concern in the acute care 
hospital setting. The best practice recommendation is to assess risk factors that predict 
OSRD before managing a patient with opioid treatment to ensure the safest care possible 
(TJC, 2012). However, there is no scoring tool that has been developed or tested that 
screens patients based on their prediction of OSRD on admission. A tool that assists 
nurses in assessing risk would support decision-making for appropriate interventions to 
manage risk and provide optimum pain management and monitoring. Conducting this 
study was the first step in creating a tool, based on predictors of OSRD, to support nurses 
and increase patient safety. In Chapter 2, I will describe the literature that provided a 
foundation and basis for this study.  
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Chapter 2: Literature Review 
Introduction 
Pain assessment and management is an integral part of nursing care. Opioids are 
one of the interventions utilized to manage pain within the hospital setting, therefore, a 
full understanding of the risks of oversedation is essential. The opioid epidemic has 
revealed the negative side effects of opioids, and many people are becoming more aware 
of the dangers. In the hospital setting, opioid adverse drug events are described as OSRD 
and are reported by TJC (2012) as occurring in 0.5% of postsurgical patients, which is 
considered a low estimation. While identifying patients who may be at high risk for 
OSRD is suggested by the TJC, there is no standardized method for screening; instead, 
what exists is a list of potential risk factors for use in hospitals.  
To identify patients at risk of OSRD, facilities can include the following risk 
factors in their policy and education for clinicians: (a) age greater than 55 years old, (b) 
obesity, (c) untreated OSA, (d) preexisting pulmonary/cardiac disease or dysfunction, (e) 
major organ failure, (f) being a smoker, (g) ASA Patient Status Classification 3–5, (h) 
being opioid naïve, (i) opioid tolerance and are given more than their usual amount, (j) 
high dose PCA pump patients, (k) in the first 24 hours of opioid therapy, (l) the presence 
of thoracic and other large incisions that may interfere with adequate ventilation, (m) 
concomitant administration of sedating agents, and (n) patients who have already 
received Naloxone for opioid reversal (Jungquist et al., 2017). However, the development 
of a scoring tool based on predictors that screen patients for risk of OSRD is not 
available. Such a tool would allow nurses to assess risk and provide appropriate 
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interventions to manage risks while providing optimum pain management and 
monitoring. A screening tool that encompasses and weighs the risk factors for OSRD 
appropriately can assist clinicians in pain assessment and management. 
In this chapter, I review the search strategies used to identify literature on OSRD 
and describe the theoretical foundation that served as a guide for the study as well as the 
rationale. A synthesis of the literature on OSRD, including the methodologies of such 
studies, follows. Then, OSRD will be explained along with similar terms that describe the 
phenomena. Last, a complete description of the risk factors for OSRD with their 
supporting evidence with the historical factors or comorbidities are listed.  
Literature Search Strategy 
I used multiple databases to gather all the available evidence on the phenomena of 
OSRD for this literature search. The term opioid-induced sedation and respiratory 
depression was first searched in CINAHL and Medline databases combined, and 41 
publications were found. Of these, the responses and letters to editors were excluded as 
well as those that were not pertinent to the phenomena upon review. The remaining nine 
articles included seven articles from various organizations that offer practice 
recommendations on the prevention and monitoring of OSRD. In exploring the medical 
subject heading terms of two pertinent studies, naloxone administration and dosage and 
hospitalized, was added to narrow down the search from 641 articles, mainly on the use 
of Naloxone outside of the hospital, to five that were about hospitalized patients. Out of 
these, I found two research articles that explored risk factors and predictors of Naloxone 
use for respiratory depression and oversedation in hospitalized patients. Next, the medical 
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subject heading term, respiratory insufficiency chemically induced, was combined with 
opioid and searched, which led to 237 articles, many pertaining to outpatient prescription 
pain management. Several articles also pertained to those patients with chronic pain. 
Next, risk factors were added to be searched with respiratory insufficiency chemically 
induced, and 55 articles were found. When reviewed, I realized that pertinent articles 
from this group had already been located from previous searches.  
Subsequently, I also completed the following searches with other terminology 
found in the literature. Opioid-induced ventilatory impairment was searched, returning 
seven total articles, two of which had already been located and reviewed; however, I also 
found an article explaining opioids, ventilation, and acute pain management which was 
added to the literature review. Opioid-induced respiratory depression was searched next, 
resulting in 333 initial articles found. Combining those search results with the term risk 
factors led to 39 articles. Twelve of these 39 articles were duplicates of those found 
previously, but three new studies were found, including a study of predictors of 
oversedation. A study looking at patients on opioids and their risk of respiratory arrest 
and another about evaluating the factors associated with Naloxone use for reversal of 
OIRD were also found. Opioid-induced sedation was searched next, initially revealing 
108 articles; many of the articles dealt with the assessment of sedation postopioid 
administration. When risk factors were added to the search, the 10 resulting articles were 
duplicates of those already located.  
In the CINAHL and Medline databases, I found 33 articles that pertained to the 
phenomena. Fifteen of these were research studies, four were based on closed claims, and 
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11 were analyzing risk factors associated with OSRD. The remaining articles were 
practice recommendations on prevention and monitoring of OSRD.  
In ProQuest, I searched both the Health and Medical and Nursing and Allied 
Health databases. The same terms were used as described previously, resulting in 897 
articles, which was narrowed to 115 when the term risk factors was added to the search. 
Of those, 16 were reviewed for content, three of which were research studies found in the 
previous search. The remaining 13 were reviews from nursing organizations: Three were 
from the pharmacology databases to assist in a better understanding of opioids and their 
action. I also searched PubMed using the search terms previously mentioned and 
combined. Out of 107 articles, 11 were pertinent to the phenomena and had already been 
identified in other databases.  
Lastly, I completed a search of Google Scholar using the terms opioid-induced 
respiratory depression and risk factors, which initially produced 1,120 articles. When the 
search was narrowed to articles published after 2015, only one remained. Other articles 
that had cited this one remaining article were reviewed for further pertinent studies. I 
searched the other studies and reviewed the other articles that cited them for further 
pertinent research, locating two more studies to include in the literature review.  
Theoretical Foundation 
Cognitive Continuum Theory (CCT) 
Assessing patients, including their risk for unplanned events, is crucial in making 
decisions for interventions. A simplified tool that assesses for risk factors of OSRD can 
assist in quick analysis and decision-making when managing pain with opioids. For this 
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reason, I chose the CCT, introduced by Hammond (1988), as the theoretical foundation 
for this study. CCT is a theory that aids in understanding the judgment and decision-
making process (Cader, et al., 2005).  
Decision-making can almost be automatic in the day-to-day care of a patient, and 
there are often nursing skills that are carried out almost automatically, while others 
require more thought and deliberation. In CCT, “the more structured a task is, the more 
analytically induced will be the decision-making mode” (Cader et al., 2005, p. 399). In 
other words, tools provide organization to support well-structured tasks. Hammond 
described tasks as being either well-structured or ill-structured; however, both types of 
tasks are relevant in nursing and defined in the CCT (Cader et al., 2005). A tool based on 
the factors that most predict OSRD could assist in providing more structure to the task of 
risk assessment.  
Intuition is also crucial for clinical decision-making in practice, and the CCT 
describes it as well. Although a tool can assist and support decisions, nurses are 
accountable and able to use a complete patient assessment, along with clinical judgment, 
to provide care to patients. CCT includes the concept of quasirationality, which is the 
combination of two types of thought: intuitive and analytical (Dhami & Thomson, 2012). 
Dhami and Thomson (2012) described quasirationality regarding managerial activity, but 
many of the descriptions transfer well to nursing. The ability to use critical thinking and 
judgment compares to using analytical information along with nursing intuition to make 
informed decisions. Successful managers must use both intuitive thinking along with 
analytical thinking (Dhami & Thomson, 2012). In assessing and managing the risk of 
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oversedation from opioids, nurses can use a tool to support analytical thinking along with 
their clinical judgment or intuition.  
Nursing uses the CCT as a method for guiding analysis. For example, Offredy, 
Kendall, and Goodman (2007) described the theory to explore nurses’ decision-making. 
They used case scenarios and interviews to assess how nurses made their prescribing 
decisions based on the CCT matrix (Offredy et al., 2008). Muir (2004) explained and 
described the debate in nursing as it relates to clinical decision-making. With some 
theories supporting analytical or intuitive strategies for decision-making in nursing, there 
is indeed a middle ground where the CCT offers acknowledgment to both types of 
thinking within the CCT matrix (Muir, 2004).  
While a tool may only address the analytical thought spectrum, an understanding 
that nurses make decisions based on a combination of analytical thought, with the use of 
tools making them well structured, along with intuitive thinking. The CCT supported the 
overall purpose of developing a tool that assesses for risk factors. The risk factors for 
OSRD are what I used to address the research question of this study. 
Literature Review Related to Key Variables and Concepts  
The published literature provides a good understanding of the overall problem of 
OSRD and the risk factors for OSRD; however, there is a gap in an understanding of the 
risk factors that potentially predict OSRD due to lack of consensus regarding these 
factors. In this section, I discuss the methodologies and approach of published studies on 
the risk factors for OSRD, the concept of OSRD, and the historical factors that are most 
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supported in the literature for predicting OSRD. Utilizing the risk factors in the literature 
and the results of this study, a screening tool was created for future research. 
Synthesis of Studies on the Predictors of OSRD 
In the following section, I review studies in the extant literature that sought to 
describe, identify, and/or predict the risk factors associated with OSRD. I found 10 
published studies that analyzed and described OSRD in surgical and medical patients 
with varying risk factors (i.e., Brant et al., 2018; Gordon, 2005; Khelemsky et al., 2015; 
Lee et al., 2015; Pawasauskas et al., 2014; Ramachandran et al., 2011; Rosenfeld et al., 
2016; Taylor et al., 2005; Weingarten et al., 2015; Weingarten et al., 2016). They are all 
nonexperimental and retrospective with both descriptive studies and case-control studies 
contributing to the current body of evidence in relation to the risk factors for OSRD.  
A descriptive study is one that describes something that already exists and is not 
correlating or predicting relationships (Houser, 2015). Descriptive data are useful in 
providing knowledge on a sample, in this case, patients who had succumbed to OSRD. 
Khelemsky et al. (2015), Lee et al. (2015), and Rosenfeld et al. (2016) all completed 
retrospective descriptive studies that provided a good base for comparison of incidence 
and overall occurrences of OSRD within the hospitalized patient population. Rosenfeld et 
al. reported incidences of OSRD in surgical patients of 3.8 per 1,000 and 2.0 per1,000 in 
medical patients, determining surgical patients with continuous opioid infusions are at the 
highest risk for OSRD. Khelemsky et al. reported the incidence of OSRD at 0.1% out of 
442,699 cases reviewed. Gupta et al. (2018) reported incidence in their descriptive 
analysis as ranging from 0.16% up to 0.53% when this data could be obtained and 
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reported in their review of several studies. These studies support the TJC’s (2012) 
estimation of 0.5% of surgical patients succumb to OSRD despite assumptions of 
underreporting in their publication.  
One retrospective study described the overall incidence of solely nonsurgical 
patients (Herzig, Rotherberg, Cheung, Ngo, & Marcantonio, 2014). These researchers 
reported the incidence of a respiratory event in their population as 0.97%. This report was 
interesting because this number is higher than the reports on the surgical population 
alone. The studies that examined both surgical and medical cases of Naloxone 
administration, however, reported a higher occurrence of surgical patients over medical 
patients experiencing an episode. Brant et al. (2018) found 55% of cases surgical with the 
remaining medical, and Rosenfeld et al. (2016) reported the incidence of medical 
Naloxone administrations at 0.2%. More attention has been focused on surgical 
occurrences of OSRD, likely due to more patients being prescribed opioids for acute pain 
related to a surgical procedure.  
A case-control analysis assists researchers to compare differences between 
individuals who experience an occurrence or outcome to individuals who do not (Houser, 
2015). A case-control analysis is a nonexperimental study where there are intact groups 
that are carefully sampled to ensure quality of data to infer causality (Houser, 2015). The 
retrospective studies on the risk factors for OSRD have different case-control sampling 
methods and statistical analysis depending on their overall intent of the study.  
In their case-control analysis examining Naloxone as a potential measure of 
quality and safety in pain management, Gordon and Pellino (2005) found differences in 
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comorbidities between the Naloxone group and the control group, matched by surgical 
procedure and time. One difference was the age which revealed that patients who 
received Naloxone were older and received other concomitant central nervous system 
depressants. Their review supports the use of Naloxone as a measurement of OSRD as 
the group that received Naloxone reversal, had increased sedation, decreased respirations 
and oxygen saturation because of being managed with opioids for pain and processes 
could be put in place to address these concerns (Gordon & Pellino, 2005). The use of 
Naloxone as an indicator of OSRD is supported in many of the other studies (Khelmesky, 
2015, Pawasauskas, 2014, and Rosenfeld, 2016) and will be used in this research.  
Ramachandran et al. (2011) completed a chi-square analysis in their case-control 
study to compare the risk factor prevalence of patients who had a postoperative critical 
respiratory event receiving opioids for pain, with the overall prevalence of postoperative 
patients. The analysis revealed an overall prevalence of congestive heart failure, 
postoperative acute renal failure, OSA, and dysrhythmias to be statistically significantly 
higher in the critical respiratory events group (Ramachandran, 2011). Likewise, 
Pawasauskas (2014) compared risk factors between a case group that received Naloxone 
for OSRD and control group that did not, matched based on the amount of opioids 
received. The results of their comparison showed renal disease, cardiac disease, 
respiratory disease, use of other sedating medications, and positive smoking status as 
statistically significant between the groups.  
Regression analysis was used in multiple case-control studies to determine if a 
predictive relationship of risk factors existed in the following studies. Taylor et al.’s 
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study (2005), utilized a matched case-control sampling design and the control was chosen 
randomly and then paired based on surgical procedure and diagnosis-related group. The 
logistic regression analysis found age, COPD, being on hydromorphone or having one of 
the following in their medical history: heart disease, congestive heart failure, respiratory 
disease, OSA, kidney disease, end-stage renal disease, and/or liver disease, were 
predictors for a respiratory event compared to a control group (Taylor, 2005). Weingarten 
et al. (2015, 2016) studied predictors in postoperative patients in a case-control study 
matched with two controls based on age, sex, and surgical procedure. They found OSA 
and events in the recovery room to be significant predictors of ORSD. In another 
analysis, Weingarten et al. (2016) reviewed Naloxone administration within the recovery 
room and matched the sample the same as their other analysis. This study reports OSA, 
an ASA score greater than 3, and high opioid requirements as predictors of a respiratory 
event (Weingarten et al., 2016). In Brant et al.’s (2018) study, a sample of hospitalized 
patients was obtained in reverse chronological order until the desired sample size was 
reached. This study utilized a regression model to determine if there were predictive 
relationships between risk factors and oversedation and respiratory depression events. 
They reported that female sex, renal disease, untreated OSA, receiving long-acting 
opioids, and as needed hydromorphone, were predictors of an episode of sedation or 
respiratory depression (Brant et al., 2018).  
Opioid-Induced Sedation and Respiratory Depression (OSRD)   
OSRD is the associated sedation or decreased level of consciousness that occurs 
with or without respiratory depression which is considered a respiratory rate decreased 
25 
 
from a patient’s typical rate, after opioid administration (Pasero & McCaffery, 2011). 
Often these events require the reversal of the opioid using Naloxone, an opioid 
antagonist. Other terms published in the literature with similar meanings include opioid-
induced sedation, OIRD, OIVI. These are defined following, but for this research are 
encompassed in this definition of OSRD.  
Opioid-induced sedation. This is included in the definition of OSRD. However, 
it is also described separately in the literature as it is recognized as a precursor of 
respiratory depression (Pasero & McCaffery, 2011). Therefore, the assessment of 
sedation is paramount in the detection of opioid adverse events early.  
Opioid-induced respiratory depression (OIRD). OIRD is defined as the 
respiratory rate and depth which is reduced below the patient's baseline after an opioid 
(Pasero & McCaffery, 2011). While rates at less than 8 breaths a minute are considered 
severe (Dahan et al., 2010), in their review, Gupta et.al. defined OIRD as “respiratory 
rate less than 10/min, and/or oxygen saturation less than 90%, Naloxone administration, 
other respiratory events like apnea, hypopnea, respiratory failure, and excessive sedation 
and upper airway obstruction" (2018, p.111). This definition defined their inclusion of a 
literature review determining which studies examined risk factors about the same 
outcome of OIRD. 
Opioid-induced ventilatory impairment (OIVI). OIVI is explained as being 
caused by the depression of the central nervous system after opioid administration, which 
causes a decrease in respiratory drive and cognitive function and impacts the strength of 
the muscles in the airway (Macintyre et al., 2011). Acute pain management with opioids 
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can be dangerous, especially if titrating solely to a pain score (Macintyre et al., 2011). 
OIVI is especially concerning for patients with OSA, where opioids compound concerns 
with airway that are already present (Macintyre et al., 2011) 
Predictors of Opioid-Induced Sedation and Respiratory Depression 
The following is the factors that will be included in the retrospective review to 
determine how they predict OSRD to OSRD to utilize in the tool development 
subsequent this analysis. There are many factors that place a patient at risk for OSRD. 
This study sought to determine which factors, present on admission, which are the 
historical risk factors.  
Historical risk factors are those factors from the medical history. Many of these 
risk factors are described by TJC (2012) and the Society for Pain Management nursing 
practice recommendations (2011) as characteristics of patients who are at higher risk for 
OSRDs (The Joint Commission, 2012; Jarzyna et al., 2011). These factors include 
demographics and diagnosis that could be screened upon admission and would not 
necessarily change throughout the hospitalization and include: obstructive sleep apnea, 
obesity, age, pulmonary disease, cardiac disease, major organ failure, diabetes mellitus, 
opioid naïve, previous opioid use, ASA score, and others not fully supported in the 
literature like Smoking, gender and neurological disease. 
Gender is a demographic factor and is known to play a role in the 
pharmacogenetics as males and females experience pain and metabolize pain treatments 
differently (Packiasbapathy & Sadhasivam, 2018). Brant et al. (2018), list female sex as a 
significant predictor of OSRD while Minkowitz et al. (2014) list male sex as a risk factor. 
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Because there is a known difference pharmacodynamically with conflicting evidence 
supporting each gender as a factor, gender will be used in sampling and matching case-
controls for this study. 
OSA. OSA (also known as suspected sleep apnea or sleep-disordered breathing) 
is a factor which has been identified as a risk factor for an adverse opioid event. 
Jungquist et al., (2018) published a review of the literature on OSA and how to prevent 
OIRD. “Ninety percent of patients with sleep-disordered breathing are undiagnosed” 
(Jungquist et al., 2018, p. 602). This emphasizes the need to screen for undiagnosed sleep 
apnea. Tools exist to screen for this preoperatively (Meisenberg, Ness, Rao, Rhule, & 
Ley, 2017). STOP-BANG is a tool developed to screen patients based on a simple 
questionnaire that alerts practitioners to a potential for undiagnosed OSA (Chung et al., 
2012). It consists of nine factors or questions that accumulate to a risk score. If greater 
than three factors are present, there is a high risk of having undiagnosed OSA (Chung et 
al., 2012).  
The recommended care for OSA surgical patients and patients who screen 
positive for OSA, but require surgery, include appropriate use of CPAP machines, 
monitoring post operatively and using an opioid sparing technique (Jungquist et al., 
2018). Using opioid sparing techniques to prevent OSRD is recommended but is not 
always feasible in every surgical or medical population because the type of surgery may 
not allow for a regional block and monitoring is critical. Gupta et al. (2018) published a 
review of risk factors for OSRD and noted that even in small doses, opioids could cause 
OSRD in patients with OSA. Out of the 13 studies included in their review, four reported 
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a statistically significant association of OSA. In their study of postoperative patients who 
suffered a critical respiratory event, not only was OSA listed as a risk factor, 3 of the 4 
patients who died due to the critical respiratory event had a diagnosis of OSA. While it 
may be one of the strongest predictors, it is also associated with more severe episodes of 
OSRD, including death (Ramachandran et al., 2011). 
Obesity. A BMI greater than 30 kg/m2 is considered obese and morbid obesity is 
a BMI greater than 35 kg/m2. Morbid obesity, per TJC, is one of the characteristics of 
patients who are at higher risk of OSRD, because they are at higher risk of having sleep 
apnea (The Joint Commission, 2012). Meisenberg, et al. (2017) completed a retrospective 
analysis of OSRD, and knowledge assessment of staff before implementing EMR bundles 
and found that one of the most common risk factors was obesity. In Khelemsky et al.’s 
(2015) study, the average BMI for those receiving Naloxone was 27 kg/m2 as a part of 
their descriptive analysis.  
Age. Meisenberg et al. (2017) found that age greater than 60 increased risk for 
OSRD. Gupta et al. (2018) described the mean age of studies in their synthesis of 13 
different studies were greater than 60 years in eight of the studies, but three reported an 
age greater than 50 years as significant. Other retrospective reviews also list age as a 
contributing risk factor to OSRD (Felhofer, 2013, Minkowitz et al., 2014,). TJC 
delineated the “risk is 2.8 times higher for individuals aged 61-70, 5.4 times higher for 
age 71-80 and 8.7 times higher for those over 80” (TJC, 2012, p. 2) for OSRD. Therefore, 
the risk increases as age increases.  
Pulmonary disease. Pawasauskas, et al. (2014), retrospectively analyzed 
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patients’ medical records who received Naloxone for OSRD and examined the patient 
characteristics that have been reported in the literature. Results revealed that patients who 
required Naloxone had 5.1 risk factors as opposed to their control that had 3.3 risk 
factors. One of the factors was respiratory disease. Dahan, Overdyk, Smith, Aarts, and 
Niesters (2013) published a systematic analysis of case reports of opioid-induced OIRD 
events, which showed a predictable pattern of respiratory disease that needs to be 
considered when administering opioids to chronic pain patients. In Phase 1 Naloxone 
reversals, matched for case-control analysis, pulmonary disease was one of the 
statistically significant factors contributing to the need for Naloxone reversal. While it 
may seem that pulmonary disease is synonymous with obstructive sleep apnea, they both 
add as a stand-alone factor in OSRD.  
Cardiac disease. Cardiac disease or heart disease is a broad term which is a 
disease of the heart or blood vessels (American Heart Association, 2017). Ramachandran 
et al. (2011) concluded that congestive heart failure, cardiac dysrhythmias, coronary 
artery disease, and hypertension were all strongly associated OSRD in their retrospective 
study. This study likewise included these diagnoses as positive for cardiac disease. 
Major organ failure. Renal failure is likely a risk factor due to the kidneys 
requirement to clear the opioids from the system and build up can be detrimental 
(Conway et al., 2006). Postoperative acute renal failure is one factor specifically thought 
to increase OSRD in patients on opioid therapy for acute surgical pain (Ramachandran et 
al., 2011). Liver failure is listed as a risk factor likely due to the first-pass metabolism of 
Morphine, a common opioid (Casey, 2018).  
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Diabetes mellitus. DM is a factor not included in the TJC factors. Gupta et al. 
(2018) determined a history of DM was statistically significant in as a contributor to 
OSRD in two of the studies included in their review, and of high percentage in another. 
Therefore, DM was included as a factor in this study. 
Previous opioid use. Patients who utilize opioids regularly at home are 
considered opioid-tolerant, meaning they have developed a pharmacological tolerance to 
the opioid and may require an increased dose (Cooney & Broglio, 2017). Their pain can 
be challenging to manage in the hospital setting and may require frequent, increasing 
dosing of opioids (dose stacking), which can increase their risk for OIRD (Jungquist, 
2017). For these patients, the pharmacists are often consulted to determine the patient ’s 
equianalgesic dosing requirements and assist in planning for appropriate dosing and 
monitoring. Patients who have had no opioid use at home are at increased risk for OSRD 
due to the potentially increased sensitivity to opioids. 
ASA score. The ASA scores is determined by considering the patient’s 
comorbidities, medications and need for surgery before a patient receives anesthesia. 
ASA scores range from 1 to 6 with an allowance for E for emergencies. Higher scores 
mean a patient has more comorbid factors that make anesthesia riskier. ASA score greater 
than 3 was one of the three highest factors in Felhofer’s study which examined which 
patients would be the best candidates for capnography monitoring post opioid 
administration based on their risk (Felhofer, 2013).  
With an understanding of the methodologies and approaches of OSRD and the 
supporting literature for the concepts and variables for this study, the published literature 
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provides an understanding of the overall problem of OSRD. There is a variety of risk 
factors for OSRD, some present on admission as a historical factor and others that arise 
during the hospitalization. Due to the lack of consensus regarding these factors, there 
remains a gap in the risk factors ability to predict OSRD.  
Summary 
OSRD is known in the literature as a serious safety concern and an understanding 
of the factors that predict OSRD is not fully known. In this chapter, I reviewed the search 
strategies performed utilizing the various terminology, synonyms that describe the 
phenomena of OSRD, and the factors that predict it. The CCT is the theoretical 
underpinning that supports nursing decision making and the foundation of understanding 
the predictability of the risk factors for OSRD to make better decisions in care. A review 
of the literature revealed several retrospective case-control studies that support the factors 
in predicting OSRD, however, the studies also had varying results. Although there were 
some factors that were supported by more than one study, there was not a consistent list 
recurring from each analysis. The factors in the literature that could be screened upon 
admission and would not necessarily change throughout the hospitalization include: 
OSA, obesity, age, pulmonary disease, cardiac disease, major organ failure, DM, and no 
previous opioid use. In Chapter 3, I will describe the methodology that was used in my 
study to answer the research question and further fill the gap that exists in medical 
literature. 
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Chapter 3: Research Method 
Introduction 
While the risk factors for OSRD are available in the literature (e.g., Jarzyna et al., 
2011, Jungquist et al., 2017, TJC, 2012), no scoring tool has been developed or tested for 
use in screening patients for OSRD risk. The purpose of this study was to create a 
prediction model based on published risk factors for OSRD. In Chapter 3, I describe the 
research design, methodology, threats to validity, and ethical considerations of the study.  
Research Design and Rationale 
In this study, I used the quantitative method and a retrospective, case-control 
design. The dependent variable was what distinguished the case from the control, the 
presence of OSRD. OSRD was measured by the administration of Naloxone for opioid 
reversal. The descriptive variables that were used in sample matching were the surgical 
procedure/admitting medical diagnosis and sex. The independent variables were risk 
factors for OSRD and had been identified in previous research. These risk factors were 
OSA, obesity, age, pulmonary disease, cardiac disease, major organ failure, DM, and no 
previous opioid exposure. This design allowed me to extract the risk factor data elements 
that were then statistically analyzed to address the research question concerning the 
prediction of OSRD.  
I compared the risk factors for OSRD between those who experienced OSRD and 
those who did not, which allowed risk and prediction between whole groups to occur (see 
Houser, 2015). A case-control design was the most commonly used method to determine 
the risk factors for OSRD (Brant et al., 2018; Gordon & Pellino, 2005; Pawasakas et al., 
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2014; Ramachandran et al., 2011; Taylor et al., 2005; Weingarten & Biphenyls, 2015; 
Weingarten et al., 2016). In the previous studies, groups were organized and selected by 
whether the patients experienced OSRD (or a similar event) or not. I used this same 
approach to determine which variables place the patient at the highest risk for developing 
OSRD. I used a retrospective approach to test the predictive model, although I 
acknowledged that the best determinant of reliability and validity is prospective. 
However, due to the limited number of patients who experience OSRD, a prospective 
study was beyond the scope of this study because it would have required an extended 
period to identify and obtain data (see Houser, 2015).  
Methodology 
Population 
Medical records of hospitalized medical and surgical patients in an acute care 
hospital who were managed with opioids for pain was the target population for this study. 
The National Center for Health Statistics reported 35,061 hospital admissions for varying 
diagnoses in the United States in 2015 (Centers for Disease Control, 2017). There is not 
an estimation of how many patients are treated with opioids within these hospitalizations, 
but with a focus on adequate pain management, opioids are a foundation of treatment 
(Macintyre, 2011). For the purposes of this study, I used the term, pain 
management, synonymously with opioid use, and every patient should be screened for 
risk of OSRD upon admission (see TJC, 2012).  
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Sampling and Sampling Procedures 
I used convenience sampling to extract the cases that I needed for the case group 
and the control group. Group 1 was the case group of individuals who had OSRD, and 
Group 2 was the control group of patients who have not had ORSD. I accessed records 
using a report from the acute care hospital system where I conducted my research after 
obtaining approval to access the data. The outcome measure of naloxone administrations 
was already being collected at the facility and was entitled the “Narcan Report.”  
Inclusion criteria for Group 1. For Group 1, the inclusion criteria were patient 
records who received Narcan and were over 18 years of age. Patients from Group 1 were 
excluded if they received Naloxone but had not received opioids within the 4 hours 
before administration. This assumes they received Naloxone as a last resort when no 
other reason was present for decreased respirations that were easily identified. 
Inclusion criteria for Group 2. For Group 2, the inclusion criteria were patient 
records who were also over 18 years of age and were matched to Group 1 based on their 
medical diagnosis on admission or surgical procedure type and gender. The other 
descriptor factors used in other studies, like age, were not used as matching in this study 
because age is also a known predictor of OSRD and pairing based on this would have 
excluded it as a potential predictor. 
To determine the sample size, I used G*power software. G*power is a software 
that can calculate the effect size to determine the number of cases needed in a sample 
(Faul, Erdfelder, Buchner, & Lang, 2009). I used a logistic regression, a priori power 
analysis with two tails, an odds ratio of 2.3, power of .80, with a binomial distribution to 
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calculate a total sample size of 196 to run the analysis. In the acute care 100 to 199 bed 
hospital system where I collected data from, naloxone reversal was given at a decreasing 
rate of .2% per 1,000 patient days in 2018. Naloxone reversal was .8% in 2014. The most 
recent 100 patients that met the inclusion criteria were included for Group 1. Group 2 
included 100 patients that were matched for a total of 200 patients, which exceeded the 
power analysis calculation. 
Procedures for Data Collection 
Because this was a retrospective chart review, it fell under Walden University’s 
Institutional Review Board (IRB) policy approving exempt studies using existing data, if 
deidentified, for research purposes. I obtained IRB exempt status before any data 
extraction or collection procedure. After IRB approval from the hospital facility, I 
contacted the pharmacy liaison and information services department to receive the 
naloxone report and a report of discharged patient records that matched per sampling 
method for Group 2. To collect the data for Group 1, I extracted cases from the naloxone 
report and then retrieved specific information on the variable from the patient record. The 
information I recorded were the patient’s age, gender, medical diagnosis or surgical 
procedure, and whether they had OSA, obesity, pulmonary disease, cardiac disease, 
major organ failure, DM, and/or no opioid exposure. 
After I recorded the information for Group 1, I searched the discharged patient 
report, which was provided to me by the information services department at the hospital, 
to extract Group 2. I matched cases based on the patients’ medical diagnosis or surgical 
procedure and gender. I then obtained the matched patient’s age, and whether they had 
36 
 
OSA, obesity, pulmonary disease, cardiac disease, major organ failure, DM, and no 
opioid exposure. 
Instrumentation and Operationalization of Constructs 
I reviewed patient records from an electronic medical record system utilizing an 
Excel worksheet. Patient records were the mainstay of sources used in the previously 
published articles related to risk factors for ORSD (i.e., Brant et al., 2018; Gordon & 
Pellino, 2005; Pawasakas et al., 2014; Ramachandran et al., 2011; Taylor et al., 2005; 
Weingarten & Biphenyls, 2015; Weingarten et al., 2016). Review of the charts allowed 
me to extract the descriptive and independent variables from the patient records using 
deidentified case numbers (see Appendix A). 
The variables described in the study were operationalized as follows. The 
dependent variable was whether the patient succumbed to OSRD. I measured it by the 
administration of naloxone after opioid administration representing an episode of OSRD. 
This was a categorical variable of yes = 0 and no = 1 in the Excel spreadsheet. The two 
descriptive constructs were pulled and applied to match the case with the control. 
Surgical procedure or admitting medical diagnosis and the patient’s sex were recorded 
and matched accordingly.  
 The independent variables, which were also descriptive, were those risk factors 
most evidenced in the literature that were present on admission. Both weight and age 
were recorded as continuous variables. Weight was documented as BMI in the patient 
record, and age was calculated per the date of birth in the record. The remaining 
independent variables were all categorical and were represented by a diagnosis present of 
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yes = 0 or no = 1. Presence of OSA included a diagnosis of OSA or suspected OSA 
where a patient screened positive using the STOP-BANG score of 3 or more. STOP-
BANG is a tool developed to screen patients based on a simple questionnaire that alerts 
practitioners to a potential for undiagnosed OSA (Chung et al., 2012). The presence of 
pulmonary disease was determined via diagnosis of COPD, asthma, or being a current 
smoker. Determination of cardiac disease included the diagnosis of congestive heart 
failure, cardiac dysrhythmias, coronary artery disease, and hypertension. Major organ 
failure was identified with diagnosis of either renal or liver failure. DM was identified 
with a diagnosis also. Last, no opioid exposure was identified as yes if the patient was not 
currently taking an opioid prescription.  
Data Analysis Plan 
I used Statistical Package for the Social Sciences Version 24 to calculate a step-
wise logistic regression to determine which risk factors are most predictive for OSRD. 
Logistic regression is used when there is more than one independent variable and the 
dependent variable is categorical (Warner, 2013). Logistic regression supports the ability 
to determine how well the independent variables predict the dependent variables and 
avoid confounding effects that may occur when analyzed separately (Sperendei, 2014). 
Therefore, logistic regression applied to my data analysis because this study was the first 
step in determining which variables should be included in the final prediction model and 
subsequent tool with multiple independent variables (see Sperendei, 2014). Another 
analysis that could have been used to determine the differences between the two groups 
would have been chi-square tests. Chi square was used by Ramachandran et al. (2011) to 
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compare means of cases of two groups, and this determined if there were differences 
between the risk factors of those who have OSRD and those who do not, but it did not 
determine the predictability of the factors.  
Threats to Validity 
Internal Validity 
One of the threats to the internal validity of this study was the use of secondary 
data because initial recording of the data cannot be controlled but is considered a highly 
accurate source of objective data (see Houser, 2015). To minimize selection effects of the 
data, I was the only researcher retrieving the secondary data in this study. I ensured that 
the same documents were used to document data for each patient record. The admission 
history, physician history, and physical assessment were the main areas that I searched 
for the risk factors in this study (see Houser, 2015). The definitions of the variables being 
retrieved remained constant in both the case and control groups and the data dictionary 
(see Appendix B), providing a definition of each item in clear view. Selection effects that 
can cause an unequal distribution between subjects were controlled through the matching 
of subjects (see Houser, 2015).  
External Validity 
Time and history effects due to the case sample being obtained from a report over 
the course of several years was an external validity threat because different interventions 
and care may have been occurring during various periods. To minimize these threats, I 
when possible, retrieved the control sample from a similar time frame as the matched 
case (see Houser, 2015). This was not always possible, so there is an external threat to the 
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validity of the results because the interventions and actions in a certain timeframe may 
have been different than another, which limits the generalizability of the results (see 
Houser, 2015).  
Statistical Conclusion Validity 
To control for statistical conclusion validity, the design of the study needs to align 
with the question being answered by the statistical analysis (see Houser, 2015). In this 
study, I utilized a comparison group that was matched based on criteria to provide 
backing for the conclusion validity. I also clearly defined the variables of interest to help 
support the validity of the statistical analysis completed.  
Ethical Procedures 
Before any data collection, I obtained IRB approval from both Walden University 
and the hospital where the patient records were reviewed. The information services 
department of the hospital required IRB approval prior to assisting in the location of 
records that met the inclusion and exclusion criteria for study groups. The risk that this 
research presented was minimal because there were no actual human participants in the 
study, solely the records of patients previously cared for. Data were de-identified so that 
no information I collected could identify a patient after extraction. I kept the Excel 
spreadsheet in a password-protected folder only accessible by me. The de-identified data 
will be maintained for 5 years per Walden IRB policy. The study was conducted within 
my own work environment, which allowed for the opportunity to access the study 
sample; however, the policies and procedures of both IRBs in the accession of data were 
strictly followed.  
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Summary 
  This retrospective, case-control study was the first step in the creation of a 
screening tool for risk of OSRD by determining how well the risk factors predict OSRD. 
This design was supported in the literature as appropriate for the variables presented and 
the subsequent analysis completed. The sample was precisely matched, and variables 
were meticulously extracted from the electronic medical record for accuracy to 
subsequently develop a tool with a sound foundation. A logistic regression model built 
with the independent variables that are most predictive of OSRD lent itself to the 
development of a tool based on the factors that most predict OSRD, excluding those with 
little odds of increasing OSRD. Data were de-identified and protection of human subjects 
was maintained through anonymity. I report the results of my study in Chapter 4.  
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Chapter 4: Results  
Introduction 
An understanding of how risk factors predict OSRD can assist in the assessment 
of risk after opioid administration. The purpose of this quantitative study was to create a 
prediction model with the known risk factors for OSRD to determine how well they 
predict OSRD. In this chapter, I explain the data collection, statistical tests performed, 
and the results to answer the research question and hypotheses posed:  
Research Question: What combination of factors most accurately predict the risk 
of OSRD in patients on admission to an acute care healthcare institution? 
H0: The independent variables, which included the continuous variables of 
obesity, measured in BMI and age, and categorical variables as diagnosed 
yes or no, which included OSA, pulmonary disease, cardiac disease, major 
organ failure, diabetes mellitus, and no opioid exposure, do not predict the 
risk of OSRD.  
HA: The independent variables, which included the continuous variables of 
obesity, measured in BMI and age, and categorical variables as diagnosed 
yes or no, which included OSA, pulmonary disease, cardiac disease, major 
organ failure, diabetes mellitus, and no opioid exposure, predict the risk of 
OSRD. 
Data Collection 
 After I obtained IRB approval (Approval Number 1442958-1), data were 
collected through a retrospective chart review from an acute care, nonprofit, community 
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hospital system. Data from the first group of records were labeled as Group 1 and 
represented the case participants of records from patients who had received naloxone 
after an opioid administration. The most recent 100 records of patients admitted during 
2019, 2018 and 2017 were included in the study. Records were reviewed for the 
following factors: surgical procedure or medical diagnosis, gender, BMI, age, OSA, 
pulmonary disease, cardiac disease, major organ failure, DM, and whether the patient was 
considered opioid naïve. Active smoking was added as criteria for pulmonary disease. 
Major organ failure was reexamined and named renal failure because, in this sample, 
renal failure was the only major organ failure noted. The factors described above were 
listed and organized on a spreadsheet with the corresponding data for each of the 100 
patient records reviewed (see Appendix C). The data for each of the factors were 
extracted from each patient record. No individual identifiers were used in the study 
spreadsheet.  
 Once the collection of Group 1 data was completed, the surgical procedure or 
medical diagnosis and gender was shared with the hospital’s information technology 
department who assisted me in obtaining data for Group 2, the control group. The 
medical diagnosis group was more difficult to obtain because patients had numerous 
admitting diagnoses. These were matched randomly by using the first patient, organized 
in reverse chronological order from May 2019 to January of 2019, who had either the 
same or the same category or type of diagnosis and gender. Once the records were 
selected each of the records was reviewed for gender, BMI, age, OSA, pulmonary 
disease, cardiac disease, renal failure, DM, and whether they were considered opioid 
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naïve. Data were then listed and organized on a spreadsheet (see Appendix D). No 
individual identifiers were used in the study spreadsheet. 
Table 1 shows the matched demographics of the 200 patient records included in 
the study. The sample included 136 total surgical patient records (i.e., 68 in Group 1 and 
68 in Group 2) from various procedure types, including cardiac catheter procedure, 
general surgical procedures, gynecological procedures, neurosurgical procedures, 
orthopedic procedures, urological procedures and vascular procedures. There were 64 
(i.e., 32 in Group 1 and 32 in Group 2) medical patient records from a variety of 
admitting diagnoses categorized as cardiac or respiratory diagnosis, gastrointestinal 
diagnosis, infection diagnosis, neurological diagnosis, and oncological diagnosis. The 
sample for Group 1 had a higher percentage of surgical (68%) over medical (32%) and 
female records (72%) over male records (28%). Therefore, the sample for Group 2 was 
matched to the Group 1 sample; the sample was randomly extracted based on the first 
surgical or medical procedure and gender, male or female, that corresponded from the 
report provided by the information technology department.  
Table 1 denotes the matched demographics of the records included in the study. In 
the surgical procedure group (n = 136, 68% of total sample), the highest represented type 
was orthopedic (n = 36, 26% of surgical records), followed closely by vascular (n = 34, 
25% of surgical records) and general surgery (n = 34, 25% of surgical records) cases. 
Neurosurgical, urological, gynecological, and cardiac catheter procedures are represented 
but in small quantities. The medical diagnosis group (n = 64, 32% of total sample) is 
represented highest by those admitted for gastrointestinal issues (n = 24, 38% of medical 
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records), such as small bowel obstruction and pancreatitis, followed closely by cardiac 
and respiratory diagnoses (n = 22, 34% of medical records), like shortness of breath. 
Infection, neurological, and oncological diagnosis are represented but in smaller quantity. 
The overall sample consisted of 144 (72%) female patient records, this made up 73.5% of 
the surgical records (n = 100) and 68.7% of the medical records (n = 44). There were 66 
(28%) male patient records, which made up 26.5% of the surgical records and 31.2% of 
the medical records for the entire sample.  
  
45 
 
Table 1 
Matched Demographics 
  Group 1  Group 2 
Factor Total n 
(%) 
Group 
n 
% 
Female 
% 
Male 
 Group 
n 
% 
Female 
% 
Male 
n 200 (100) 100 72 28  100 72 28 
Surgical  
 
136 (68) 68 73.5 26.5  68 73.5 26.5 
Cardiac catheter 2  1 100 0  1 100 0 
General 34 17 100 0  17 100 0 
Gynecological 6 3 100 0  3 100 0 
Neurosurgical 14 7 57 43  7 57 43 
Orthopedic 36 18 83 17  18 83 17 
Urological 10 5 40 60  5 40 60 
Vascular 34 17 47 53  17 47 53 
         
Medical  
 
64 (32) 32 68.7 31.3  32 68.7 31.3 
Cardiac or 
respiratory 
22 11 91 9  11 91 9 
Gastrointestinal 24 12 58.3 41.7  12 58.3 41.7 
Infection 8 4 25 75  4 25 75 
Neurological 6 3 66.7 33.3  3 66.7 33.3 
Oncological 4 2 50 50  2 50 50 
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Medical records of hospitalized medical and surgical patients in an acute care 
hospital who were managed with opioids for pain was the target population for this study. 
The National Center for Health Statistics reported 35,061 hospital admissions for various 
diagnoses in the United States in 2015 (Centers for Disease Control, 2017). I assumed 
that there is a range of percentages of both surgical and medical admissions in hospitals 
nationwide, but the actual data are unknown. At this community-based healthcare system, 
there were 26,638 hospital admissions in 2018 and each hospital ranged from 31% to 
46% surgical and 54% to 69% medical. The sample obtained for OSRD represented a 
higher surgical volume, likely due to higher amount of opioid prescriptions for acute 
pain.  
Study Results  
Study Sample 
Table 2 denotes the descriptive data of the characteristics that represent the risk 
factors for OSRD. The table shows the total sample as well as the sample per group, 
subdivided into surgical and medical patients. Group 1 had a slightly lower BMI average 
than Group 2 at 28.3 kg/m2 and 28.9 kg/m2, respectively. The remaining characteristics 
of age, OSA, pulmonary disease (including being an active smoker), cardiac disease, 
renal failure, DM, and being opioid naïve were all higher in Group 1 than Group 2. The 
average age for Group 1 was 67.5 years and for Group 2 was 66 years. OSA was present 
in 30 patient records for Group 1 and two patient records for Group 2. Pulmonary disease 
was present in 37 patient records in Group 1 and 27 patient records in Group 2. Renal 
failure was present in 38 patient records in Group 1 and 25 patient records for Group 2. 
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DM was present in 45 patient records in Group 1 and 38 records in Group 2. Lastly, 81 
patients in Group 1 were opioid naïve where Group 2 had 79 opioid naïve patient records. 
 
Assumptions of Binary Logistic Regression 
1. The outcome variable is dichotomous. This is an assumption to ensure the 
dependent variable is binary, with only two options (Warner, 2013). In this study, 
OSRD was the dependent variable and was binary with either yes = being present 
or no = not being present.  
2. The scores must be statistically independent of each other, meaning they are not 
intercorrelated (Warner, 2013). Intercorrelated variables means the independent 
variables are increased because they have a relationship with each other separate 
from the outcome variable (Salmeron, Garcia, & Garcia, 2018). To test this, I first 
analyzed each of the independent variables for multicollinearity by using a linear 
regression and analyzing each independent variable against the others. The 
variance inflation factor (VIF) estimates how much of the variance is inflated 
because of dependence on the other independent variable or predictor (Salmeron, 
et al., 2018). There is a varying opinion on acceptable VIF scores, a VIF score of 
less than 4 is considered acceptable in assuming there the predictor variables are 
not intercorrelated (Salmeron et al., 2018). When BMI was tested for collinearity, 
the VIF score for age was 1.159, OSA was 1.086, pulmonary disease was 1.079, 
cardiac disease was 1.276, renal disease was 1.147, diabetes was 1.190, and 
opioid naïve was 1.038. When age was tested for collinearity, the VIF scores for 
OSA was 1.150, pulmonary disease was 1.072, cardiac disease was 1.144, renal 
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disease was 1.164, diabetes was 1.280, opioid naïve was 1.023, and BMI was 
1.183. When OSA was tested for collinearity, the VIF scores for pulmonary 
disease was 1.036, cardiac disease was 1.285, renal disease was 1.183, diabetes 
was 1.278, opioid naïve was 1.043, BMI was 1.191, and age was 1.236. When 
pulmonary disease was tested for collinearity, the VIF scores for cardiac disease 
was 1.292, renal disease was 1.175, diabetes was 1.267, opioid naïve was 1.044, 
BMI was 1.264, age was 1.231, and OSA was 1.106. When cardiac disease was 
tested for collinearity, the VIF scores for renal disease was 1.136, diabetes was 
1.237, opioid naïve was 1.049, BMI was 1.248, age was 1.095, OSA was 1.145, 
and pulmonary disease was 1.078. When renal disease was tested for collinearity, 
the VIF scores for diabetes was 1.180, opioid naïve was 1.048, BMI was 1.227, 
age was 1.219, OSA was 1.153, pulmonary disease was 1.072, and cardiac disease 
was 1.243. When diabetes was tested for collinearity, the VIF scores of opioid 
naïve was 1.04, BMI was 1.177, age was 1.24, OSA was 1.151, pulmonary 
disease was 1.068, cardiac disease was 1.251, and renal disease was 1.091. When 
opioid naïve was tested for collinearity, BMI was 1.252, age was 1.21, OSA was 
1.147, pulmonary disease was 1.075, cardiac disease was 1.294, renal disease was 
1.183, and diabetes was 1.269. When put into the analysis individually, all the 
variables had VIF very close to 1, which is the minimum value and all were less 
than 2. This meets the assumption that there is no intercorrelation between the 
predictor variables (see Appendix E).  
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3. All relevant predictors are assumed to be present in the model (Warner, 2013). 
Based on evidence, the predictors included are those that were thought to predict 
OSRD and are present on admission.  
4. Based on sampling methodology, the 200 records were assumed to be mutually 
exclusive, meaning cases of Group 1 are different patient records than cases in 
Group 2 (see Warner, 2013).  
5. I used a logistic regression, a priori power analysis with two tails, an odds ratio of 
2.3, power of .80, with a binomial distribution to calculate a total sample size of 
196 was needed to run the analysis. The sample size I used in this study was large 
enough (N = 200).  
Research Question Results 
To answer the question fully, three different binary logistic regressions were 
performed. First, a binary logistic regression analysis was performed to determine the 
predictors of OSRD. The outcome variable of OSRD was coded as “0” for having OSRD 
and “1” for not having OSRD after opioid administration. Eight predictor variables were 
included. BMI and age as continuous variables and OSA, pulmonary disease, cardiac 
disease, renal failure, diabetes and opioid naïve. Each was coded as “0” if diagnosis was 
present or “1” if diagnosis not present. The binary logistic regression procedure was 
performed in Statistical Package for the Social Sciences Version 24. Data from 200 
patient records, described above, were included in this analysis as described above.  
A test of the full model against the null hypothesis model was statistically 
significant X2 (1) = 34.714 p = .000. The strength of the association of the predictor 
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variables to OSRD was weak with Cox & Snell’s R2 of .159 and Nagelkerke’s = R2 .212. 
Hosmer Lemeshow goodness of fit test was not statistically significant p = .526, therefore 
the model fits the data. The model predicted 62 % of the individuals who had OSRD and 
75 % of the individuals who did not experience OSRD. Therefore 38 individuals were 
false positives and 25 false negatives. Overall model prediction occurrence was 68.5 %.  
 The output in Table 2 shows the raw score of the binary logistic regression 
coefficients, Wald statistics, and the estimated change in odds of OSRD for individuals 
with the presence of the diagnosis. The odds ratio Exp (B) of 1 indicates no change in 
odds of having OSRD. The results greater than 1 indicate a positive relationship based on 
BMI, age, or having the diagnosis or suspected diagnosis of OSA. BMI, age and 
obstructive sleep apnea are very close to 1 and therefore do not change the probability of 
having OSRD. Cardiac disease (p = .207, Exp (B) =1.675, 95% CI, .752-3.732), DM (p = 
.272, Exp (B) = 1.485, 95% CI, .733-3.008) and opioid naïve (p = .202, Exp (B) =1.653, 
95% CI, .763-3.581) patients are greater than 1 and increase the likelihood of having 
OSRD, but the results were not significant. Pulmonary disease and renal disease 
increased the odds of OSRD and are statistically significant with pulmonary having a p 
value of .001, Exp (B) =3.706 (95% CI, 1.747-7.862) and renal disease having a p value 
of .004, Exp (B) = 3.084 (95% CI, 1.432-6.643).  
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Table 2 
Variables in the Equation 
 B S.E. Wald df Sig. 
Exp(B
) 
95% C.I.for 
EXP(B) 
Lower Upper 
Step 1a BMI -.003 .027 .016 1 .899 .997 .945 1.051 
Age .001 .012 .007 1 .935 1.001 .977 1.025 
OSA .136 .452 .091 1 .763 1.146 .472 2.780 
Pulmonary 1.310 .384 11.658 1 .001 3.706 1.747 7.862 
Cardiac .516 .409 1.594 1 .207 1.675 .752 3.732 
Renal 1.126 .391 8.279 1 .004 3.084 1.432 6.643 
Diabetes .396 .360 1.208 1 .272 1.485 .733 3.008 
Opioid 
Naive 
.503 .394 1.625 1 .202 1.653 .763 3.581 
Constant -2.400 1.485 2.610 1 .106 .091   
a. Variable(s) entered on step 1: BMI, Age, OSA, Pulmonary, Cardiac, Renal, Diabetes, 
Opioid Naive. 
Next a forward stepwise binary logistic regression was completed to further 
analyze pulmonary disease and renal disease, the variables that were statistically 
significant, utilizing the same data and coding in the previous analysis. A test of the full 
model against the null hypothesis model was statistically significant in Step 1 X2 (1) = 
15.417 p = .000 and Step 2 X2 (1) = 28.737 p = .000. The strength of the association of 
the predictor variables to OSRD in step 1 was weak with a Cox & Snell’s R2 of .074 and 
Nagelkerke’s = R2 .099. The strength of the association of the predictor variables to 
OSRD in Step 2 was weak with a Cox & Snell’s R2 of .134 and Nagelkerke’s = R2 .178. 
Hosmer Lemeshow goodness of fit test is not statistically significant p = .999, therefore 
the model fits the data.  
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Table 3 summarizes the variables in the equation. Step 1 included renal disease 
only. The odds ratio Exp (B) was 3.765 (95% CI, 1.88-7.539) and statistically significant, 
p= .000 therefore if renal disease is a single diagnosis, the patient has an increased 
likelihood of succumbing to OSRD after opioid administration. When renal disease was 
combined with pulmonary disease in Step 2, the presence of both diseases were 
statistically significant with p = .000. The odds ratio Exp (B) of pulmonary disease is 
3.610 (95% CI, 1.760-7.403) and renal disease is 3.767 (95% CI, 1.843-7.702), therefore 
with both diseases, the likelihood of OSRD after the administration of an opioid is even 
higher with the strength of the relationship increasing from a Nagelkerke’s = R2 .099 in 
Step 1 to Nagelkerke’s = R2 .178 in step 2.  
Table 3 
Step-Wise Variables in the Equation 
 
 B S.E. Wald df Sig. Exp(B) 
95% C.I.for EXP(B) 
Lower Upper 
Step 1a Renal 1.326 .354 14.005 1 .000 3.765 1.880 7.539 
Constant -.999 .313 10.201 1 .001 .368   
Step 2b Pulmonary 1.284 .366 12.275 1 .000 3.610 1.760 7.403 
Renal 1.326 .365 13.215 1 .000 3.767 1.843 7.702 
Constant -1.971 .440 20.051 1 .000 .139   
a. Variable(s) entered on step 1: Renal. 
b. Variable(s) entered on step 2: Pulmonary. 
 
A final binary logistic regression was completed with the variables in the previous 
procedures that increased odds of OSRD. BMI, age, and OSA were removed due to their 
Exp (B) not increasing the odds of OSRD in the first procedure. A test of the full model 
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against the null hypothesis model was statistically significant X2 (1) = 34.560 p = .000. 
The strength of the association of the predictor variables to OSRD was weak with Cox & 
Snell’s R2 of .159 and Nagelkerke’s = R2 .212. This final binary logistic regression has 
the same Nagelkerke’s R2, despite having 3 variables removed from previous procedures. 
Hosmer Lemeshow goodness of fit test was not statistically significant p = .899, therefore 
the model fits the data. 
Table 4 summarizes the variables included which were pulmonary disease (p = 
.000, Exp (B), 3.781), renal disease (p = .004, Exp (B), 3.043), cardiac disease (p = .169, 
Exp (B), 1.688), diabetes (p = .220, Exp (B), 1.524), and opioid naïve (p = .203, Exp (B), 
1.639). Pulmonary disease and renal disease remained the only statistically significant 
variables, p = .000 and p = .004, with increasing odds of OSRD at 3.781 and 3.043 which 
means every variable included increases the likelihood of OSRD after opioids, but 
pulmonary and renal disease have a higher likelihood of doing so with the Nagelkerke’s = 
R2 .212, the same as the full model with all the variables included.  
Table 4 
Final Variables in the Equation 
 
 B S.E. Wald df Sig. Exp(B) 
Step 1a Pulmonary 1.330 .376 12.487 1 .000 3.781 
Renal 1.113 .383 8.460 1 .004 3.043 
Cardiac .524 .381 1.889 1 .169 1.688 
Diabetes .421 .344 1.503 1 .220 1.524 
Opioid Naive .494 .388 1.621 1 .203 1.639 
Constant -2.337 .499 21.945 1 .000 .097 
a. Variable(s) entered on step 1: Pulmonary, Renal, Cardiac, Diabetes, Opioid Naive. 
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To answer the question posed, this final model combined with two statistically 
significant variables (pulmonary and renal) and those with increased odds of OSRD 
although not statistically significant (cardiac, diabetes, and opioid naïve) determined the 
factors that most accurately predict OSRD.  
Summary 
 Based on the results of the analysis, the factors that most predict OSRD are the 
diagnosis of pulmonary disease, renal disease, cardiac disease, DM and being opioid 
naïve. The null hypothesis is rejected as the results revealed five factors that predict 
OSRD. Although only pulmonary disease and renal disease were statistically significant, 
the final model includes other factors that increase the odds of OSRD. These will be 
included in the development of a tool to predict OSRD. In Chapter 5, I will provide an 
interpretation of the results of the study, limitations, recommendations for future 
research, including a tool to be validated through expert opinion, implications, and 
conclusions.   
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Chapter 5: Discussion, Conclusions, and Recommendations 
Introduction 
To determine the factors that predict OSRD on admission, I conducted a 
retrospective, case-control analysis was completed. The factors that most accurately 
predict OSRD are the presence of pulmonary disease, renal disease, cardiac disease, 
diabetes, and being opioid naïve. The null hypothesis was rejected because there are 
factors that predict OSRD. Although only pulmonary disease and renal disease were 
statistically significant, the final model includes other factors that increase the odds of 
OSRD. These factors will be included in the development of a tool to predict OSRD. In 
this chapter, I provide an interpretation of the results of the study, the limitations, and 
recommendations for future research. A tool will be presented for subsequent studies that 
will gain expert opinion on the factors and provide reliability and validity testing.  
Interpretation of Findings 
The published literature supported the overall problem of OSRD and the risk 
factors for OSRD (Brant et al., 2018; Gordon & Pellino, 2005; TJC, 2012; Khelemsky et 
al., 2015; Lee et al., 2015; Pawasauskas et al., 2014; Ramachandran et al., 2011; 
Rosenfeld et al., 2016; Taylor et al., 2005; Weingarten & Biphenyls, 2015; Weingarten et 
al., 2016). However, there was a gap in an understanding of the risk factors that 
potentially predict OSRD due to lack of consensus regarding these factors, specifically 
those present on admission. In this study, I sought to increase knowledge about the 
factors present on admission by understanding how well they predict OSRD.  
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Descriptive Statistics and the Literature 
The descriptive results of this study have many similarities and some differences 
to the sample populations of other studies in the literature that sought to better understand 
OSRD. The findings of this study confirmed results of studies that found a higher 
occurrence of OSRD in the surgical population over the medical population. Of the 
studies that examined both medical and surgical populations (i.e., Brant et al., 2018; 
Rosenfeld et al., 2015), the surgical population succumbed more frequently to OSRD. 
This is likely because of the higher doses required to manage acute pain in the surgical 
population. Previous studies examined only the surgical populations and reported the 
types of surgical procedures that most often had OSRD (see Gupta et al., 2018). The 
results of the current study confirmed other study demographics with patients undergoing 
orthopedic procedures as the highest number in the case group, those who succumbed to 
OSRD, comprising 18% of the surgical sample (see Gupta et al., 2018; Lee et al., 2005; 
Weingarten et al., 2016). General surgical procedures comprised 17% of the surgical 
sample in this study. These proportions aligned with the literature, which stated the 
general surgical population may be at higher risk (Ramachandran et al., 2011; Rosenfeld 
et al., 2016; Taylor et al., 2005; Weingarten & Biphenyls, 2015). I found that vascular 
procedures comprised 17% of the remaining surgical population of my sample. These 
procedures consisted of amputations and procedures to restore blood flow to extremities. 
Interestingly, these cases are not known to be in high volume in other literature; however, 
the comorbidities in this patient population are often diabetes and renal failure, which are 
known risk factors for OSRD (Gupta et al., 2018). Matching the cases with controls to 
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include these types of procedures with their comorbidities adds to the validity of the 
results of this study because the procedure types with the common diagnoses of patients 
is important to determine the true predictability of the factors, not because the control did 
not match the case adequately.  
The percentage of female patients in this study confirmed other retrospective 
reviews that also had a higher percentage of female patients who succumb to OSRD 
(Brant et al., 2018; Gupta et al., 2018; Khelemsky et al., 2015). Females composed 72% 
of the case sample in this study, which was matched in the control group. This amount is 
slightly higher than what other studies reported (i.e., Brant et al., 2018; Gupta et al., 
2018; Khelemsky et al., 2015). In studies that focused on OSA for predicting OSRD, the 
sample consisted of mostly males, which is a risk factor for OSA (Blake et al., 2008). 
Neither OSA nor obesity statistically predicted OSRD in my study, which may be 
because of the predominately female population; however, due to matching based on 
gender, predictability for gender was not determined. 
Incidence of naloxone administration during the time of data collection (i.e., 
November 2016 to April 2019) ranged from 0.2% to 0.6%. Gupta et al. (2018) reported 
the incidence of OSRD in their descriptive analysis ranging from 0.16% up to 0.53%. 
The studies in Gupta’s analysis support the TJC (2012) estimation of 0.5% of surgical 
patients succumb to OSRD despite assumptions of underreporting of the incidence of 
OSRD to TJC. Therefore, when compared with other studies in the literature, the 
naloxone administration incidence at the facility under study was within a similar range 
of other reported samples.  
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Case-Control Result Comparison 
The results of the current study extend the knowledge in the field on the topic and 
confirm other the findings of similar studies that used the case-control design to predict 
the risk factors for OSRD. However, no other study had the same purpose as this study, 
which was to look only at factors present on admission and not throughout the 
hospitalization. Therefore, this is the first study to look only at the factors on admission.  
Ramachandran et al. (2011) completed a chi-square analysis in a case-control 
study to compare the risk factor prevalence of patients who had a postoperative critical 
respiratory event receiving opioids for pain with the overall prevalence of the risk factors 
of postoperative patients. While the controls were different for the current study, 
Ramachandran et al. found renal failure to be a statistically significant risk factor. They 
also found statistically significant differences between risk factors of patients who had a 
postoperative critical event compared to the prevalence of these factors in their overall 
postoperative patients for congestive heart failure, dysrhythmias, and OSA. While the 
results of my study showed that the risk for OSRD increased with cardiac disease and 
OSA, there was not statistical significance. There may be a practical significance in 
including cardiac disease and OSA in a final tool, even without statistical significance, 
due to the confirmation of the increased odds of OSRD with the presence of cardiac 
disease and OSA.  
Brant et al. (2018) examined the risk factors in case control groups and similarly 
found renal disease to be a statistically significant risk factor of OSRD; however, they 
also found female sex, untreated sleep apnea, receipt of long-acting oxycodone, and use 
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of hydromorphone as predictors. Brant et al. did not include matching based on procedure 
or gender, which may be the reason for the differences in results. Brant et al. also 
examined patient factors throughout the hospital stay in relation to the opioids received, 
which is beneficial in planning management of pain for at risk patients.  
Pawasauskas et al. (2014) compared risk factors between a case group that 
received Naloxone for OSRD and control group that did not, and matched cases based on 
the number of opioids received, which limited the understanding of the treatment 
potential similar to Brant et al.’s findings. However, Pawasauskas et al. showed that at 
different opioid consumption levels, some patients succumbed to OSRD more readily 
than others. The results of their comparison showed renal disease, cardiac disease, 
respiratory disease, use of other sedating medications, and positive smoking status as 
statistically significant between the groups. My study findings confirmed Pawasauskas et 
al.’s results of renal disease and respiratory disease (which includes positive smoking 
status) and the increased risk of cardiac disease, which although not statistically 
significant, did show an increased risk of OSRD.  
Weingarten & Biphenyls (2015) studied predictors in postoperative patients in a 
case-control matched study with two controls based on age, sex, and surgical procedure. 
They found OSA and events in the recovery room to be significant predictors of ORSD 
along with OSA, COPD, and DM. In another analysis, Weingarten et al. (2016) reviewed 
Naloxone administration within the recovery room and matched the sample the same as 
their other analysis. They reported OSA, an ASA score greater than 3, and high opioid 
requirements as predictors of a respiratory event as well as OSA, COPD, cardiac disease, 
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and neurologic disease (Weingarten et al., 2016). In both Weingarten studies, the case 
and controls were matched similarly, although Weingarten only examined the 
postsurgical population in both studies. The results of my study confirmed characteristics 
from both of Weingarten’s studies of COPD as statistically significant of predicting 
ORSD and the increased risk of ORSD if a patient has OSA and diabetes (Weingarten & 
Biphenyls, 2015) as well as OSA and cardiac disease (Weingarten et al., 2016).  
In relation to the CCT, the results of this study assisted in the development of a 
tool that, once validated, will aid in the decision-making process of how much opioid to 
administer within a prescribed range and what monitoring may be used to prevent OSRD. 
The tool provides structure and organization to a task that assists in better decision-
making in providing pain management with opioids (Cader et al., 2005). The theory also 
contains the concept of intuition, which is a clinician’s critical thinking and judgment that 
influences prioritizing the management of pain with opioids and monitoring of a patient 
postopioid administration (Cader et al., 2005). Knowing a patient is at high risk based on 
a well-structured task, or in this case, screening tool, offers itself to better clinical 
decision-making.  
The advantage of only examining risk factors present on admission substantiates 
the purpose of this study and narrowed the focus from all the risk factors in the literature 
throughout the continuum of care. This allowed for a magnified view of factors to be 
screened on admission in a simplified tool. Understanding the factors that place a patient 
at risk for ORSD admission may influence the way practitioners choose to manage pain 
throughout the hospitalization. Therefore, knowing oxycodone and hydromorphone 
61 
 
increase the risk of OSRD (Brant et al., 2018), can assist in the development of an order 
set that avoids this type of opioid for pain management or patients that screen for risk of 
ORSD on admission.  
Limitations  
 Per the power calculations, the sample size used in this study was sufficient; 
however, a larger sample size may have lent itself to greater generalizability of results. 
Matching based on surgical procedure and gender allowed for a more focused analysis.  
However, matching also limited the ability to determine if surgical procedure or gender 
predicted risk.  
Retrospective studies are limited in their generalizability due to not being 
prospective or being able to randomize into the groups (Houser, 2013). Although I chose 
the control randomly to assist in rigor, retrospective data are not as strong as prospective 
data (see Houser, 2015). Retrospective data also limited the ability to accurately ascertain 
two variables: undiagnosed OSA and opioid naivety. It was difficult to examine 
undiagnosed OSA because the institution where I obtained the sample began screening 
regularly for undiagnosed sleep apnea in 2018 and only in the surgical population. This 
factor might not have been captured or conveyed due to the lack of standardized 
screening, especially in the medical patient population. This is likewise the case for 
determining if a patient is opioid naïve or not. Although the medications a patient was 
prescribed at home was obtained, it is difficult to know if a patient was consuming the 
opioids due to their “as needed” prescription. A detailed patient interview would be 
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needed to accurately obtain the amount a patient was taking of an “as needed” 
prescription.  
Although many surgical and medical patients were represented in this sample, it 
was only from one community-based hospital system. Therefore, the pool of patients was 
limited to the types of surgical procedures performed and medical diagnoses that are 
cared for in a single setting. This is another limiter of generalizability to all surgical and 
medical populations that are admitted across the country and world daily that may be 
different depending on their region or specialty hospital type.  
Based on documentation of an opioid administration followed by sedation scores 
and respiratory rates, each patient in the case group was verified to need the administered 
naloxone which I used as the determination of OSRD in this study. However, it is 
possible that patients who received naloxone were having neurological or respiratory 
difficulties for reasons other than opioid administration, and therefore, the sample may 
not have captured all patients who had an OSRD event in the hospital during this time 
period. It is also likely that patients had OSRD but did not receive naloxone and so they 
were not captured in these data.  
Recommendations  
In their analysis Pawasakas et al (2014), determined “the overall number of risk 
factors, not necessarily the type of risk factor combinations played a large role in 
determining risk” (p. 749). Based on the results of my study, this is confirmed as the 
individuals in the case group, Group 1, had an average of 3.05 factors out of the six 
variables to include in the tool which are OSA, cardiac disease, opioid naïve, DM, 
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pulmonary disease, and renal disease while the control group, Group 2, only had 2.16 on 
average. Based on this knowledge and the varying factors in all the samples, a tool that 
adds the number of risk factors and weights those with statistical significance higher to 
determine risk on admission may be the best option for a screening tool for OSRD. A 
draft of the Opioid-Induced Sedation and Respiratory Depression Screening Tool for 
future research includes; OSA, Cardiac disease, opioid naïve, DM counted as 1 point 
each and pulmonary disease and renal disease counted as 2 points each.   
This retrospective analysis, along with the literature and theoretical underpinnings 
to provide structured tasks to assist in decision making, provided the background 
knowledge need to draft the tool explained above. Because age and BMI, did not show 
increased a patient’s risk, they were excluded from the draft tool. OSA, although also not 
shown to increase risk in my data, but evidenced most frequently in other literature, will 
remain. Cardiac disease, DM, and opioid naïve factors all increase the odds of OSRD and 
although they were not statistically significant, they added to the overall model with 
pulmonary and renal disease which were statistically significant.  
Initial testing of the tool drafted with these data was completed, adding the risk 
factors present in Group 1 and Group 2 and using the weights of 1 point if a diagnosis 
was present for OSA, cardiac disease, opioid naïve and DM and 2 points for pulmonary 
disease and renal disease. If the cutoff point is 3, the number of false negatives in Group 
1 is 26 and the number of false positives in Group 2 is 40. Because determining risk for 
OSRD is the purpose of this tool, false positives where a patient is screened at risk even 
though they may not succumb to OSRD is a better outcome than a false negative. 
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Therefore, based on the results of this study, the final tool will be reviewed and assessed 
by expert opinion and validated prospectively. Once experts agree with the factors, 
prospective analysis will validate the cut point for the tool and the usefulness of the tool 
in preventing OSRD in hospitalized patients. Further research on the practice factors that 
contribute to OSRD and the differences between the factors present on admission and 
those that occur during the hospitalization to determine if one outweighs the other in 
predicting OSRD should also occur.  
Implications  
 Understanding the factors that predict OSRD to develop a screening tool could 
save lives in hospital institutions which is a positive social change. Patients have the right 
to remain free from harm in a hospital setting and appropriate tools that allow for 
screening can assist in such an endeavor. Prospective analysis for tool development 
would be difficult because OSRD occurs very infrequently. With the results of the current 
study and others in the literature, the factors present upon admission could be identified 
by screening to assist clinicians in appropriate management in both surgical and medical 
patients. Identifying risk highlights factors that might otherwise remain solely in a 
problem list upon a normal history retrieval from a patient.  
Conclusion  
 With a better understanding of OSRD, the Opioid-Induced Sedation and 
Respiratory Depression Screening Tool could be the answer to those seeking ways to 
better screen for OSRD factors. The magnified view of factors only present on admission 
lends itself to a simple screen that when completed, will highlight the risk factors that 
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may inadvertently be otherwise overlooked. Although there are more factors that lead to 
OSRD, this analysis captured those risk factors that can assist in determining care for the 
entire hospitalization therefore preventing over administration of opioids or lack of 
monitoring that can be tailored based on this screening tool. Certainly, clinical judgement 
is never replaced by a tool, but supporting decision making is essential to provide safe 
competent care in a sometimes-chaotic healthcare environment.  
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Appendix C: VIF Chart 
Variance Inflation Factor (VIF) Chart 
Dependent 
Variable 
Age 
VIF 
BMI 
VIF 
OSA 
VIF 
Pulmonary 
VIF 
Cardiac 
VIF 
Renal 
VIF 
Diabetes 
VIF 
Opioid 
Naïve 
VIF 
Age X 1.183 1.150 1.072 1.144 1.164 1.280 1.023 
BMI 1.159 X 1.086 1.079 1.276 1.147 1.19 1.038 
OSA 1.236 1.191 X 1.036 1.285 1.183 1.278 1.043 
Pulmonary 1.292 1.267 1.106 X 1.292 1.175 1.267 1.044 
Cardiac 1.095 1.248 1.145 1.078 X 1.136 1.237 1.049 
Renal 1.219 1.227 1.153 1.072 1.243 X 1.180 1.048 
Diabetes 1.240 1.177 1.151 1.068 1.251 1.091 X 1.04 
Opioid 
Naive 
1.21 1.252 1.147 1.075 1.294 1.183 1.269 X 
 
